# A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.

> **NCT00267267** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 1784 (—)

## Conditions studied

- Hyperlipidemia
- Dyslipidemia

## Interventions

- **DRUG:** torcetrapib/atorvastatin
- **DRUG:** ezetimibe/simvastatin

## Key facts

- **NCT ID:** NCT00267267
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 1784 (—)
- **Last updated:** 2007-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267267, "A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00267267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*